Clinical Trial Update: Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

View source ↗

Summary

An observational study evaluating tocilizumab (RoActemra/Actemra) in rheumatoid arthritis has completed and posted results in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-01-14